Robert E. Landry
EVP Finance CFO at Regeneron Pharmaceuticals; Director at Cytokinetics. Based in South San Francisco, California.
- Rank
- 4735th of 14,644
- Companies held
- 2
- Largest holding
- REGN, 98.1% of total
- Latest SEC filing
- Sep 15, 2026
What the $22.6M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals REGN Common Stock | Directly | 23,693 | $925.99 | $21.9M | 97.0% | Form 4, Feb 2, 2024 |
| Cytokinetics CYTK Common Stock | Directly | 8,184 | $51.53 | $422K | 1.9% | Form 4, Sep 15, 2026 |
| Regeneron Pharmaceuticals REGN Common Stock | Through 401(k) Plan | 270 | $925.99 | $250K | 1.1% | Form 4, Feb 2, 2024 |
Share counts are the amounts Robert E. Landry reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4732 | Matthew Krueger CFO, Treasurer and Secretary, Strive. Dallas, TX | $22.6M |
| 4733 | Scott McFeely SVP, Networking Platforms, Ciena. Hanover, MD | $22.6M |
| 4734 | Jan Gommaar M. Vleugels COO - INTERNATIONAL, Alliance Laundry Holdings. Ripon, WI | $22.6M |
| 4735 | Robert E. Landry EVP Finance CFO, Regeneron Pharmaceuticals. South San Francisco, CA | $22.6M |
| 4736 | Mark V Anquillare Group President and COO, Verisk Analytics. San Mateo, CA | $22.6M |
| 4737 | Sara Yang Bosco Sr VP, Secy & Chf Leg Ofc, Emerson Electric. St. Louis, MO | $22.6M |
| 4738 | Michael Tabor 10% owner, iHeartMedia | $22.6M |
Other Regeneron Pharmaceuticals insiders
All REGN insiders- Leonard S. Schleifer$2.22BBd. Co-Chair, President & CEO. #141 overall
- George Yancopoulos$857MBd. Co-Chair, President & CSO. #314 overall
- P. Roy Vagelos$433MDirector. #529 overall
- Neil E. Stahl$54.9MEVP Research and Development. #2379 overall
- Andrew Murphy$47.4MCo-Chief Scientific Officer. #2654 overall
- Joseph LaRosa$44.6MEVP General Counsel and Secret. #2771 overall
Questions
How much stock does Robert E. Landry own?
Robert E. Landry holds $22,611,220 in listed stock based on SEC filings and current prices, mostly Regeneron Pharmaceuticals (REGN). That ranks 4735th on the Stock Rich List.
Is this Robert E. Landry's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Robert E. Landry last buy or sell stock?
The most recent open-market trade on file is a sale of 1,000 CYTK shares on Sep 15, 2026 at $72.13.